Transient Asymptomatic Pulmonary Opacities During Osimertinib Treatment and its Clinical Implication

Cancer statistics, 2016

Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2016 · 16.2K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib

Thomas J. Lynch, Daphne W. Bell, Raffaella Sordella et al. · New England Journal of Medicine · 2004 · 11.5K citations

Medicine, Oncology, Pharmacology +16

<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy

J. Guillermo Paez, Pasi A. Jänne, Jeffrey C. Lee et al. · Science · 2004 · 9.4K citations

Medicine, Molecular Genetics, Oncology +17

The International Epidemiology of Lung Cancer: Latest Trends, Disparities, and Tumor Characteristics

Ting‐Yuan David Cheng, Susanna Cramb, Peter D. Baade et al. · Journal of Thoracic Oncology · 2016 · 616 citations · Full text

Medicine, Health Sciences, Oncology +17

Increased Expression of Epidermal Growth Factor Receptor (EGF-R) in Patients with Different Forms of Lung Fibrosis

Αrgyris Τzouvelekis, Paschalis Ntolios, Andreas Karameris et al. · BioMed Research International · 2013 · 57 citations · Full text

Medicine, Molecular Biology, Pathology +13